我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

老年急性冠脉综合征患者应用替罗非班治疗出血危险因素分析

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2011年第2期
页码:
218-220
栏目:
临床研究
出版日期:
2010-12-10

文章信息/Info

Title:
Risk factors of bleeding complication of tirofiban in elderly patients with acute coronary syndrome
作者:
武强1王曙霞2郭豫涛2张璐2 蔡军1
解放军总医院:1.国际医学中心,2.老年心内科,北京 100853
Author(s):
WU Qiang1 WANG Shu-xia2 GUO Yu-tao2 ZHANG Lu2 CAI Jun1
1.International Medical Center, 2.Department of Geriatric Cardiology, PLA General Hospital, Beijing 100853, China
关键词:
替罗非班出血急性冠脉综合征危险因素
Keywords:
tirofiban acute coronary syndrome safety risk factors
分类号:
R541.4;R973.2
DOI:
-
文献标识码:
A
摘要:
目的: 分析老年急性冠脉综合征(ACS)患者应用替罗非班抗血小板治疗出血的危险因素。方法: 67例年龄大于60岁的老年ACS患者接受替罗非班持续静脉滴注36~48 h,观察用药开始至停药3 d内患者出血情况,并对出血可疑危险因素进行单因素和多因素Logistic回归分析。结果: 发生出血6例(9%),其中重度出血1例,轻度出血5例。多因素Logistic回归分析表明吸烟,OR=3.2, 95%CI 2.2-4.6;年龄每增加10岁,OR=1.4,95%CI 1.1-1.7;血小板聚集率每减少10%,OR=1.6,95%CI 1.2-1.9;肌酐清除率每减少10 ml/min,OR=1.2,95%CI 1.0-1.4;抗凝药及抗血小板药每增加一个,OR=4.2, 95%CI 2.0-5.2。结论: 抗血小板与抗凝药联合应用,吸烟、高龄、血小板聚集率降低、肌酐清除率降低为老年ACS患者应用替罗非班抗血小板治疗出血的主要危险因素。
Abstract:
AIM: To evaluate the risk factors of bleeding complication of tirofiban in elderly patients with acute coronary syndrome (ACS). METHODS: A total of 67 patients (>60 years) with ACS were enrolled from August 2008 to February 2009 and were all given aspirin, clopidogrel, low molecular weight heparin, tirofiban and other anti-ischemic therapy. Tirofiban was given continuously for 36-48 h. Possible risk factors of bleeding complication analyzed included age, sex, smoking, hypertension, diabetes mellitus, blood platelet number, platelet aggregation, body mass index and creatinine clearance rate. RESULTS: Of the six bleeding patients, one patient experienced severe bleeding and five experienced mild bleeding. The results of multivariate stepwise logistic regression analysis indicated that smoking (OR=3.2, 95% CI 2.2-4.6), age (increasing every 10 years, OR=1.4, 95% CI 1.1-1.7), platelet aggregation (decreasing 10% OR=1.6, 95% CI 1.2-1.9), creatinine clearance (decreasing 10 ml/min OR=1.2, 95% CI 1.0-1.4), and anticoagulants and antiplatelet drugs (increasing one drug, OR=4.2, 95% CI 2.0-5.2) were risk factors for bleeding complication of tirofiban in elderly patients with ACS. CONCLUSION: Anticoagulants combined with antiplatelet drugs, smoking, age, platelet aggregation and creatinine clearance are risk factors for bleeding complication of tirofiban in elderly patients with acute coronary syndrome.

参考文献/References

[1]Yip HK, Chung SY, Chai HT, et al. Safety and efficacy of transradial vs transfemoral arterial primary coronary angioplasty for acute myocardial infarction: single-center experience[J]. Circ J, 2009, 73(11):2050-2055.

[2]De Queiroz Femandes Araújo JO, Veloso HH, Braga De Paiva JM, et al. Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: A meta-analysis of randomized,controlled trials[J]. Am Heart J, 2004, 148(6):937-943.

[3]张庆刚,钱琳艳,车贤达,等. 国产替罗非班对急性冠脉综合症患者急诊介入治疗安全性和有效性[J]. 心脑血管病防治, 2009, 4(9):267-269.

[4]Limbruno U, Micheli A, De Carlo M, et al. Mechanical prevention of distal embolization during primay angio-plasty: safety,feasibility, and impact on myocardial reperfusion[J]. Circulation, 2003, 108(2):171-176.

[5]Valgimigli M, Campo G, Percoco G. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial[J]. JAMA, 2008, 299(15):1788-1799.

[6]季选秀. 替罗非班在急性冠脉综合征中的应用进展[J]. 中华保健医学杂志, 2009, 11(2):156-158.

[7]宋洁,仇兴标,方唯一. 替罗非班在急性冠脉综合征中的应用[J]. 中国临床医学, 2009, 16(3):356-358.

[8]Brown DL. Deaths associated with platelet glyeoprotein IIb/IIIa inhibitor treatment[J]. Heart, 2003, 89(5):535-537.

[9]Sreedhara R, Itagaki I, Hakim RM. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors[J]. Am J kidney dis, 1996, 27(3):355-364.

[10]李卫东,张国辉,鲍中华. 替罗非班在急性心肌梗死介入治疗中的应用[J]. 江苏大学学报, 2009,19 (1):62-64.

备注/Memo

备注/Memo:
收稿日期:2010-03-24.基金项目:中央保健专项资金科研资助项目课题(205) 作者简介:武强,副主任医师Email:china301wuqiang@tom.com
更新日期/Last Update: 2010-12-10